ReviewNeuropsychiatric disease and treatment2021
Identifying Early Neuropsychological Indicators of Cognitive Involvement in Multiple Sclerosis.
Review in Neuropsychiatric disease and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 13 citations in OpenAlex.
- Can Pursuing Perfection Ignite Sparks of Creativity? How and When Self-Oriented Perfectionism Leads to Radical and Incremental Creativity.Behavioral sciences (Basel, Switzerland) · 2026Article
- Investigating functional brain networks in multiple sclerosis patients: a graph theory approach for evaluating working memory impairment.Brain informatics · 2026Article
- The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis.BMC neurology · 2026Article
- Timed 25-foot walk test is independently associated with cognitive function in multiple sclerosis: a cross-sectional study.European journal of medical research · 2025Article
- Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: an insight into the role of the AMPK/SIRT1 pathway.Inflammopharmacology · 2024Article
- Factors affecting driving performance in patients with Multiple Sclerosis - still an open question.Frontiers in neurology · 2024Article
- Physiotherapy for Multiple Sclerosis Patients From Early to Transition Phase: A Scoping Review.Cureus · 2022Article
- Short-Range Structural Connections Are More Severely Damaged in Early-Stage MS.AJNR. American journal of neuroradiology · 2022Article
- The Effect of Benson Relaxation Technique on Depression, Anxiety, and Stress of Jordanian Patients Diagnosed with Multiple Sclerosis: A Cross-Sectional Study.Depression research and treatment · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a debilitating disease of the central nervous system that is most commonly seen in early to middle adulthood, although it can be diagnosed during childhood or later in life. While cognitive impairment can become more prevalent and severe as the disease progresses, signs of cognitive involvement can be apparent in the early stages of the disease. In this review, we discuss the prevalence and types of cognitive impairment seen in early MS, including the specific measures used to identify them, as well as the challenges in characterizing their frequency and progression. In addition to examining the progression of early cognitive involvement over time, we explore the clinical factors associated with early cognitive involvement, including demographics, level of physical disability, disease modifying therapy use, vocational status, and psychological and physical symptoms. Given the prevalence and functional impact these impairments can have for persons with MS, considerations for clinicians are provided, such as the role of early cognitive screenings and the importance of comprehensive neuropsychological assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.